Europe Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

Description

List of Tables

The Europe cerebrospinal fluid management market was valued at US$ 544.31 million in 2022 and is expected to reach US$ 817.12 million by 2030; it is estimated to grow at a CAGR of 5.2% from 2022 to 2030.

R&D in the Field of CSF Management Fuels the Europe Cerebrospinal Fluid Management Market

R&D in the field of CSF management in the region is marked by a commitment to advancing medical knowledge, improving patient outcomes, and enhancing treatment modalities. European countries are renowned for their robust investments in healthcare research and innovation, making significant contributions to the field of CSF management. For example, research institutions and universities collaborate on projects aimed at improving CSF shunt systems, which are pivotal in the treatment of conditions like hydrocephalus. These collaborations often result in innovative designs, materials, and minimally invasive techniques that reduce complications and improve patient quality of life.

Furthermore, Europe is at the forefront of clinical trials related to CSF-related disorders. These trials focus on the development of novel diagnostic tools and treatments for conditions such as idiopathic intracranial hypertension (IIH) or normal pressure hydrocephalus (NPH). For instance, the ongoing research into the diagnostic criteria and treatment options for NPH is shaping the standard of care for patients. Additionally, biomarker research is advancing the ability to diagnose through cerebrospinal fluid analysis. These initiatives represent the region's focus on advancing CSF management. Thus, it is expected to bolster the growth of the market during the coming years.

Europe Cerebrospinal Fluid Management Market Overview

The Europe cerebrospinal fluid management market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Countries such as Germany and the UK are expected to be the largest contributors to the market in this region. The rising prevalence of iNPH and malignant CNS tumors are the major factors driving the growth of this market in Europe.

Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

Europe Cerebrospinal Fluid Management Market Segmentation

The Europe cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the Europe cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the Europe cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe cerebrospinal fluid management market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe cerebrospinal fluid management market share in 2022.

Argi Group Health Services Ltd Sti, B. Braun SE, Delta Surgical Ltd, Integra LifeSciences Holdings Corp, Medtronic Plc, Moller Medical GmbH, Natus Medical Inc, Sophysa SA, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the Europe cerebrospinal fluid management market.

Product Code: TIPRE00028012

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Cerebrospinal Fluid Management Market Landscape

4.1 Overview
4.2 Europe PEST Analysis

5. Europe Cerebrospinal Fluid Management Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
- 5.1.2 R&D in the Field of CSF Management
5.2 Market Restraints
- 5.2.1 Risk of Failure and Malfunctioning
5.3 Market Opportunities
- 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
5.4 Future Trends
- 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - Europe Market Analysis

6.1 Europe Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

7.1 Overview
7.2 Europe Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
7.3 CSF Shunts
- 7.3.1 Overview
- 7.3.2 CSF Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Ventriculoperitoneal Shunts
  - 7.3.3.1 Overview
  - 7.3.3.2 Ventriculoperitoneal Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Ventriculoatrial Shunts
  - 7.3.4.1 Overview
  - 7.3.4.2 Ventriculoatrial Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Ventriculopleural Shunts
  - 7.3.5.1 Overview
  - 7.3.5.2 Ventriculopleural Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Lumboperitoneal Shunts
  - 7.3.6.1 Overview
  - 7.3.6.2 Lumboperitoneal Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
7.4 CSF Drainage Systems
- 7.4.1 Overview
- 7.4.2 CSF Drainage Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 External Ventricular Drainage (EVD) Systems
  - 7.4.3.1 Overview
  - 7.4.3.2 External Ventricular Drainage (EVD) Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Lumbar Drainage (LD) Systems
  - 7.4.4.1 Overview
  - 7.4.4.2 Lumbar Drainage (LD) Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 Europe Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Clinics
- 8.4.1 Overview
- 8.4.2 Clinics: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Ambulatory Surgical Centers
- 8.5.1 Overview
- 8.5.2 Ambulatory Surgical Centers: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Cerebrospinal Fluid Management Market - Country Analysis

9.1 Overview

10. Europe Cerebrospinal Fluid Management Market -Industry Landscape

10.1 Overview
10.2 Growth Strategies in The Europe Cerebrospinal Fluid Management Market, 2020-2023
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Integra LifeSciences Holdings Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 B. Braun SE
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Argi Group Health Services Ltd Sti
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Sophysa SA
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Delta Surgical Ltd
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Moller Medical GmbH
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Natus Medical Inc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Spiegelberg GmbH & Co KG
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms